Records containing: Schizoaffective Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-11-09A Proof-of Concept Trial of Galantamine and Memantine for Cognitive Impairments in Schizophrenia: Is the Combination Effective?
-
CLINICAL_TRIALS study record update · 2017-11-07Cognitive Remediation for Perceptual Deficits in Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-10-31Combined Oxytocin and CBSST for Social Function in People With Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-10-26A Randomized Controlled Trial Comparing Joint Crisis Plans With Crisis Cards for People With Bipolar Disorders, Schizophrenia and Other Psychotic Disorders to Reduce Involuntary Admission and Coercive Measures.
-
CLINICAL_TRIALS study record update · 2017-10-12Biochemical, Physiological, and Psychological Measures in Normal Controls and Relatives of Psychiatric Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-09-29Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-09-136R-BH 4 in People With Schizophrenia and Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2017-09-11Work Activity Augmented by Cognitive Rehabilitation: Continuation and Follow-up
-
CLINICAL_TRIALS study record update · 2017-08-28Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2017-08-25Cognitive Behavioral Social Skills Training in Early-onset Psychosis: Efficacy in Psychotic Symptoms, Psyshosocial Functioning and Neurobiological and Epigenetic Stress Markers.
-
CLINICAL_TRIALS study record update · 2017-08-02Effect of an NMDA-based Intervention on Biomarker Measures of Cognitive Dysfunction in Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-07-25Randomised Controlled Trial to Evaluate the Efficacy of Cognitive Remediation Within a Secure Forensic Setting for Schizophrenia Spectrum Patients
-
CLINICAL_TRIALS study record update · 2017-07-25Prevention of Weight Gain in Early Psychoses
-
CLINICAL_TRIALS study record update · 2017-07-21Computerized Cognitive Skills Training in Severe Mental Illness
-
CLINICAL_TRIALS study record update · 2017-07-18Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness
-
CLINICAL_TRIALS study record update · 2017-06-23Implementing a Psychosocial Intervention to Reduce Self-stigma and Improve Quality of Life Among Mental Health Outpatients in Chile: a Pilot Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2017-06-08Cannabinoid Receptor Antagonist Treatment of Cognitive Dysfunction in Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-06-07Serotonin 1A Agonists and Cognition in Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-05-17An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
-
CLINICAL_TRIALS study record update · 2017-05-10D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-05-10RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia): a Cluster-randomised Trial
-
CLINICAL_TRIALS study record update · 2017-04-19Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging
-
CLINICAL_TRIALS study record update · 2017-04-18Oxytocin Treatment of Social Deficits and Paranoia in Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-04-10CAD Risk in Schizophrenia: Effect of Omega-3 Fatty Acid Supplementation
-
CLINICAL_TRIALS study record update · 2017-03-29A Sequential and Parallel Cohort Design to Test the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry